Skip to the content

IOP A community website from IOP Publishing

Welcome

Welcome to our new nanomedicine community page. Your one-stop source of news, analysis and commentary from the nanotechnology community.

For maximum exposure, become a Corporate partner. Contact our sales team.

Buyer’s Guide

Nanomedicine

Biomedical applications of nanotechnology

Talking point

Talking point RSS feed

Magnetic particle imaging: x-space options

The second article in our two-part series on magnetic particle imaging takes a look at the evolution of x-space MPI.

Magnetic particle imaging: moving ahead

In the first of a two-part series on magnetic particle imaging, we examine the latest developments in MPI hardware and nanoparticle design.

'Multidisciplinarians' set the agenda in biophotonics

Photonic technologies are undergoing a second renaissance, argues Tom Baer of the Stanford Photonics Research Center in California. So what does that mean for biomedical applications?

Physics meets biology: a convergence of interest

Advances in biophotonics and supercomputing signal a bright future for biophysics research, write Jason Crain and Will Hossack.

Editorial articles

Editorial articles RSS feed

Medical physicists: preparing for change

As the boundaries between medical disciplines become increasingly blurred and those between diagnosis, therapy and management follow suit, how can medical physicists adapt to these changing needs?

High-performance computing: shaping medicine's future

Tools such as grid networks and supercomputers will play a vital supporting role in biomedical research and clinical development.

Multimodal themes shape the BiOS agenda

A multimodality approach to diagnostics and therapeutics was one of the defining themes at the recent Biomedical Optics Symposium in San Jose, California.

Magnetic nanoparticles: the attraction is clear

Early-stage experimental studies confirm the potential of magnetic nanoparticles in a range of clinical applications.

Nanoparticles in the frame

A rigorous evaluation of toxicity and biocompatibility issues is essential if nanoparticles are to see wide-scale adoption in clinical imaging and drug-delivery applications.